Neximmune Alpha and Beta Analysis
| NEXIDelisted Stock | USD 2.43 0.22 9.95% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Neximmune. It also helps investors analyze the systematic and unsystematic risks associated with investing in Neximmune over a specified time horizon. Remember, high Neximmune's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Neximmune's market risk premium analysis include:
Beta (1.83) | Alpha (0.1) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Neximmune |
Neximmune Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Neximmune market risk premium is the additional return an investor will receive from holding Neximmune long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Neximmune. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Neximmune's performance over market.| α | -0.1 | β | -1.83 |
Neximmune Fundamentals Vs Peers
Comparing Neximmune's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Neximmune's direct or indirect competition across all of the common fundamentals between Neximmune and the related equities. This way, we can detect undervalued stocks with similar characteristics as Neximmune or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Neximmune's fundamental indicators could also be used in its relative valuation, which is a method of valuing Neximmune by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Neximmune to competition |
| Fundamentals | Neximmune | Peer Average |
| Return On Equity | -1.96 | -0.31 |
| Return On Asset | -0.7 | -0.14 |
| Current Valuation | (491.95 K) | 16.62 B |
| Shares Outstanding | 1.37 M | 571.82 M |
| Shares Owned By Insiders | 17.00 % | 10.09 % |
| Shares Owned By Institutions | 11.17 % | 39.21 % |
| Number Of Shares Shorted | 15.99 K | 4.71 M |
Neximmune Opportunities
Neximmune Return and Market Media
The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
About Neximmune Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Neximmune or other pink sheets. Alpha measures the amount that position in Neximmune has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Neximmune Upcoming Company Events
As portrayed in its financial statements, the presentation of Neximmune's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Neximmune's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Neximmune's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Neximmune. Please utilize our Beneish M Score to check the likelihood of Neximmune's management manipulating its earnings.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 30th of September 2023 Last Quarter Report | View |
Build Portfolio with Neximmune
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Neximmune Pink Sheet
If you are still planning to invest in Neximmune check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neximmune's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |